dc.creatorPérez Arancibia, Rodrigo Nicolás
dc.creatorRivas, Alexis
dc.creatorHetz Flores, Claudio
dc.date.accessioned2019-01-29T14:52:24Z
dc.date.available2019-01-29T14:52:24Z
dc.date.created2019-01-29T14:52:24Z
dc.date.issued2018
dc.identifierExpert Opinion on Therapeutic Targets, Volumen 22, Issue 2, 2018, Pages 97-100
dc.identifier17447631
dc.identifier14728222
dc.identifier10.1080/14728222.2018.1420169
dc.identifierhttps://repositorio.uchile.cl/handle/2250/161117
dc.languageen
dc.publisherTaylor and Francis Ltd
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceExpert Opinion on Therapeutic Targets
dc.subjecteIF2alpha
dc.subjectER stress
dc.subjectIRE1
dc.subjectPERK
dc.subjectprotein misfolding
dc.subjectproteostasis
dc.title(off)Targeting UPR signaling: the race toward intervening ER proteostasis
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución